159 related articles for article (PubMed ID: 30052325)
1. A Study to Assess the Proarrhythmic Potential of Mirtazapine Using Concentration-QTc (C-QTc) Analysis.
Gurkan S; Liu F; Chain A; Gutstein DE
Clin Pharmacol Drug Dev; 2019 May; 8(4):449-458. PubMed ID: 30052325
[TBL] [Abstract][Full Text] [Related]
2. Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods.
Lu J; Li J; Helmlinger G; Al-Huniti N
J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):469-482. PubMed ID: 29556866
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis.
Timmers M; Sinha V; Darpo B; Smith B; Brown R; Xue H; Ferber G; Streffer J; Russu A; Tritsmans L; Solanki B; Bogert J; Van Nueten L; Salvadore G; Nandy P
J Clin Pharmacol; 2018 Jul; 58(7):952-964. PubMed ID: 29505101
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Effect of Selumetinib on Cardiac Repolarization: A Randomized, Placebo- and Positive-controlled Crossover QT/QTc Study in Healthy Subjects.
Zhou D; So K; Dymond AW; Vik T; Al-Huniti N; Mariani G; Zorenyi G; Huang Y; Holmes V; Severin P; Rasmussen S; Martin P
Clin Ther; 2016 Dec; 38(12):2555-2566. PubMed ID: 27837934
[TBL] [Abstract][Full Text] [Related]
5. The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) study.
Cavero I; Holzgrefe H; Clements M
J Pharmacol Toxicol Methods; 2016; 80():1-8. PubMed ID: 26903171
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
[TBL] [Abstract][Full Text] [Related]
7. Deferasirox does not induce QT/QTc-prolongation in healthy subjects.
Sechaud R; Dumortier T; Balez S
Int J Clin Pharmacol Ther; 2009 May; 47(5):321-7. PubMed ID: 19473594
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers.
Hofmann C; Banken L; Hahn M; Swearingen D; Nagel S; Martin-Facklam M
Clin Ther; 2012 Oct; 34(10):2061-71. PubMed ID: 22980315
[TBL] [Abstract][Full Text] [Related]
9. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
10. Assay sensitivity in "Hybrid thorough QT/QTc (TQT)" study.
Huang DP; Chen J; Dang Q; Tsong Y
J Biopharm Stat; 2019; 29(2):378-384. PubMed ID: 30346877
[TBL] [Abstract][Full Text] [Related]
11. Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin.
Dahmane E; Hutson PR; Gobburu JVS
Clin Pharmacol Drug Dev; 2021 Jan; 10(1):78-85. PubMed ID: 32250059
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers.
Khalilieh SG; Yee KL; Fan L; Liu R; Heber W; Dunzo E; Triantafyllou I; Hussaini A; Iwamoto M
Clin Drug Investig; 2017 Oct; 37(10):975-984. PubMed ID: 28785879
[TBL] [Abstract][Full Text] [Related]
13. Effects of Celecoxib on the QTc Interval: A Thorough QT/QTc Study.
Kim S; Lee H; Ko JW; Kim JR
Clin Ther; 2019 Nov; 41(11):2204-2218. PubMed ID: 31564512
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
[TBL] [Abstract][Full Text] [Related]
15. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
[TBL] [Abstract][Full Text] [Related]
16. Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ; van Kuijk J; Smeets J; Thomsen T; Peeters P
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):595-604. PubMed ID: 22735462
[TBL] [Abstract][Full Text] [Related]
17. A Thorough QT Study to Evaluate the Effects of Supratherapeutic Doses of Ledipasvir on the QTc Interval in Healthy Subjects.
German P; Mathias A; Brainard DM; Song Q; Ling J; Kearney BP
Clin Pharmacol Drug Dev; 2018 Aug; 7(6):641-651. PubMed ID: 29058821
[TBL] [Abstract][Full Text] [Related]
18. Effects of three fluoroquinolones on QT interval in healthy adults after single doses.
Noel GJ; Natarajan J; Chien S; Hunt TL; Goodman DB; Abels R
Clin Pharmacol Ther; 2003 Apr; 73(4):292-303. PubMed ID: 12709719
[TBL] [Abstract][Full Text] [Related]
19. Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
Swaisland H; Plummer R; So K; Garnett S; Bannister W; Fabre MA; Dota C; Fielding A
Cancer Chemother Pharmacol; 2016 Oct; 78(4):775-84. PubMed ID: 27553432
[TBL] [Abstract][Full Text] [Related]
20. Virtual clinical QT exposure-response studies - A translational computational approach.
Aguado-Sierra J; Dominguez-Gomez P; Amar A; Butakoff C; Leitner M; Schaper S; Kriegl JM; Darpo B; Vazquez M; Rast G
J Pharmacol Toxicol Methods; 2024; 126():107498. PubMed ID: 38432528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]